Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux.
about
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesDrug delivery systems and combination therapy by using vinca alkaloidsDelivery of vincristine sulfate-conjugated gold nanoparticles using liposomes: a light-responsive nanocarrier with enhanced antitumor efficiencyLight-Sensitive Ruthenium Complex-Loaded Cross-linked Polymeric Nanoassemblies for the Treatment of CancerKey structure of brij for overcoming multidrug resistance in cancerSynergistic and complete reversal of the multidrug resistance of mitoxantrone hydrochloride by three-in-one multifunctional lipid-sodium glycocholate nanocarriers based on simultaneous BCRP and Bcl-2 inhibition.Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.The holistic 3M modality of drug delivery nanosystems for cancer therapy.Lipid-enveloped hybrid nanoparticles for drug delivery.Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.Nanodrug delivery in reversing multidrug resistance in cancer cells.Nanostructured lipid-carrageenan hybrid carriers (NLCCs) for controlled delivery of mitoxantrone hydrochloride to enhance anticancer activity bypassing the BCRP-mediated efflux.Nano-based strategies to overcome p-glycoprotein-mediated drug resistance.Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Nanoparticle-based drug delivery in cancer: the role of cell membrane structures.Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles.
P2860
Q26783705-094DBA88-573E-495B-A5CC-1B84F91B4FE6Q28829009-38CC8731-4DB5-4966-AD43-556D8343FF6FQ35542344-7E782FF5-12E1-4242-97C1-EF93FE93FA66Q36539791-1F9C4903-3272-4E53-B481-7D3ACE55A6B0Q36615913-E271DCA1-108C-47CF-9A9B-CD29D56F4004Q37214483-36E2E68A-A4BF-412D-8678-6BA971817C92Q37682912-7429106A-0C92-413F-B548-F0905BCB20CCQ38071901-A40222A9-7280-4C15-A92C-3FF7FF8C9540Q38071910-DF5D3768-93CE-427E-8F6C-E29CB4BB627BQ38167822-DD6CDDD3-2B5D-44F3-B02A-8E8A48FE84CCQ38234908-6C4A9A5F-32AC-4FCF-B8DF-9462B39AB6A2Q38804702-A902A36B-1904-4C61-8DCE-05B1982C19D7Q38856533-36A833E8-95C2-4E55-8251-D19AEB1F77FEQ39015939-3F1EBDA9-B693-408F-B086-401EA0AB69C7Q47440128-3CC13880-6578-4D4F-A39E-3E48DC85E330Q51118403-4EBF9F8D-1C2C-4023-8EB2-911BD60BCFD2Q53681649-3918849A-78A5-464B-8545-86C222882D2D
P2860
Multifunctional nanoassemblies for vincristine sulfate delivery to overcome multidrug resistance by escaping P-glycoprotein mediated efflux.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@en
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@nl
type
label
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@en
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@nl
prefLabel
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@en
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@nl
P2093
P1433
P1476
Multifunctional nanoassemblies ...... -glycoprotein mediated efflux.
@en
P2093
Guixia Ling
Peng Zhang
Tianhong Zhang
Yongbing Sun
Zhiyuan Wang
Zhonggui He
P304
P356
10.1016/J.BIOMATERIALS.2011.04.022
P577
2011-05-04T00:00:00Z